RS63646B1 - Isporuka lekova posredovana ultrazvukom - Google Patents
Isporuka lekova posredovana ultrazvukomInfo
- Publication number
- RS63646B1 RS63646B1 RS20220889A RSP20220889A RS63646B1 RS 63646 B1 RS63646 B1 RS 63646B1 RS 20220889 A RS20220889 A RS 20220889A RS P20220889 A RSP20220889 A RS P20220889A RS 63646 B1 RS63646 B1 RS 63646B1
- Authority
- RS
- Serbia
- Prior art keywords
- drugs
- mediated delivery
- ultrasound mediated
- ultrasound
- delivery
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 238000002604 ultrasonography Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0047—Sonopheresis, i.e. ultrasonically-enhanced transdermal delivery, electroporation of a pharmacologically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
- A61K49/0078—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion microemulsion, nanoemulsion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Acoustics & Sound (AREA)
- Physics & Mathematics (AREA)
- Radiology & Medical Imaging (AREA)
- Surgery (AREA)
- Materials Engineering (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nanotechnology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20131293 | 2013-09-27 | ||
PCT/NO2014/050177 WO2015047103A1 (en) | 2013-09-27 | 2014-09-26 | Ultrasound mediated delivery of drugs |
EP14847119.6A EP3049117B1 (en) | 2013-09-27 | 2014-09-26 | Ultrasound mediated delivery of drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
RS63646B1 true RS63646B1 (sr) | 2022-11-30 |
Family
ID=52744068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20220889A RS63646B1 (sr) | 2013-09-27 | 2014-09-26 | Isporuka lekova posredovana ultrazvukom |
Country Status (14)
Country | Link |
---|---|
US (6) | US20160243234A1 (sr) |
EP (2) | EP3049117B1 (sr) |
JP (2) | JP6876436B2 (sr) |
CN (1) | CN105658243B (sr) |
DK (1) | DK3049117T3 (sr) |
ES (2) | ES2927884T3 (sr) |
HR (1) | HRP20221118T1 (sr) |
HU (1) | HUE060034T2 (sr) |
LT (1) | LT3049117T (sr) |
PL (1) | PL3049117T3 (sr) |
PT (1) | PT3049117T (sr) |
RS (1) | RS63646B1 (sr) |
SI (1) | SI3049117T1 (sr) |
WO (1) | WO2015047103A1 (sr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190030374A1 (en) | 2014-12-19 | 2019-01-31 | Universite Pierre Et Marie Curie (Paris 6) | Implantable ultrasound generating treating device for brain treatment, apparatus comprising such device and method implementing such device |
HUE059596T2 (hu) * | 2015-11-11 | 2022-12-28 | Navifus Co Ltd | Agydaganat kezelésének módszere és készlete ultrahangos rendszer segítségével |
ES2912885T3 (es) | 2016-03-11 | 2022-05-30 | Univ Sorbonne | Dispositivo de tratamiento externo de generación de ultrasonidos para el tratamiento de la médula espinal y de los nervios espinales |
EP3426347B1 (en) | 2016-03-11 | 2024-05-15 | Sorbonne Universite | Implantable ultrasound generating treating device for spinal cord treatment and apparatus comprising such device |
US10981021B2 (en) * | 2016-03-11 | 2021-04-20 | Carthera | Method for transiently disrupting a region of the blood-brain barrier of a human |
WO2018222340A1 (en) * | 2017-05-29 | 2018-12-06 | Bionaut Labs Ltd. | Triggering of payload release from miniaturized devices |
CN111132732B (zh) * | 2017-06-29 | 2021-09-21 | 医视特有限公司 | 增强对靶组织的治疗同时限制对非靶组织的损伤的*** |
BR112020009373A2 (pt) * | 2018-01-02 | 2020-11-03 | Flodesign Sonics, Inc. | partículas para uso em processos de onda estacionária acústica |
US20220031166A1 (en) * | 2018-09-18 | 2022-02-03 | The Johns Hopkins University | Neuromodulation based nerve identification |
WO2021080438A1 (en) | 2019-10-25 | 2021-04-29 | Exact Therapeutics As | Treatment of pancreatic cancer |
GB2595513B (en) | 2020-05-29 | 2023-03-29 | Act Therapeutics Ltd | Treatment of infections |
GB2605422A (en) | 2021-03-31 | 2022-10-05 | Act Therapeutics Ltd | Treatment of the central nervous system |
GB2605996A (en) | 2021-04-21 | 2022-10-26 | Act Therapeutics Ltd | Enhancement of treatment with immunotherapeutic agents |
WO2024050075A2 (en) * | 2022-09-01 | 2024-03-07 | Microvascular Therapeutics, Llc | Methods and compositions for treatment of vascular obstruction |
NO20221061A1 (en) * | 2022-10-05 | 2024-04-08 | Exact Therapeutics As | Act enhanced ablation therapy |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5335168A (en) | 1993-01-13 | 1994-08-02 | Compaq Computer Corporation | Computer system with power-down mode for monitor |
EP0727225A3 (en) | 1995-02-14 | 1997-01-15 | Sonus Pharma Inc | Compositions and methods for directed ultrasonic imaging |
US5997898A (en) | 1995-06-06 | 1999-12-07 | Imarx Pharmaceutical Corp. | Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery |
WO1998001297A1 (en) | 1996-07-09 | 1998-01-15 | Panex Corporation | Quartz construction |
PL332820A1 (en) | 1996-10-21 | 1999-10-11 | Nycomed Imaging As | Improved contrast media |
US6416740B1 (en) | 1997-05-13 | 2002-07-09 | Bristol-Myers Squibb Medical Imaging, Inc. | Acoustically active drug delivery systems |
ATE296113T1 (de) * | 1998-02-09 | 2005-06-15 | Bracco Research Sa | Zielgerichtete abgabe von biologische-aktive medien |
US6340976B1 (en) * | 1998-04-15 | 2002-01-22 | Mitsubishi Denki Kabushiki Kaisha | Multivision system, color calibration method and display |
GB9808599D0 (en) * | 1998-04-22 | 1998-06-24 | Nycomed Imaging As | Improvements in or realting to contrast agents |
GB9808581D0 (en) * | 1998-04-22 | 1998-06-24 | Nycomed Imaging As | Improvements in or relating to contrast agents |
NO20010234D0 (no) * | 2001-01-12 | 2001-01-12 | Nycomed Imaging As | Perfusjon avbildningsbilde |
JP2005168312A (ja) * | 2003-12-08 | 2005-06-30 | Mebiopharm Co Ltd | 遺伝子類導入方法 |
WO2005063306A1 (en) * | 2003-12-22 | 2005-07-14 | Bracco Research Sa | Assembly of gas-filled microvesicle with active component for contrast imaging |
CN100427142C (zh) * | 2005-01-10 | 2008-10-22 | 重庆海扶(Hifu)技术有限公司 | 一种高强度聚焦超声治疗用助剂及其筛选方法 |
JP2007197403A (ja) * | 2006-01-30 | 2007-08-09 | Hitachi Ltd | 薬物キャリアー及び超音波装置 |
-
2014
- 2014-09-26 ES ES14847119T patent/ES2927884T3/es active Active
- 2014-09-26 EP EP14847119.6A patent/EP3049117B1/en active Active
- 2014-09-26 LT LTEPPCT/NO2014/050177T patent/LT3049117T/lt unknown
- 2014-09-26 SI SI201431993T patent/SI3049117T1/sl unknown
- 2014-09-26 RS RS20220889A patent/RS63646B1/sr unknown
- 2014-09-26 WO PCT/NO2014/050177 patent/WO2015047103A1/en active Application Filing
- 2014-09-26 PL PL14847119.6T patent/PL3049117T3/pl unknown
- 2014-09-26 HR HRP20221118TT patent/HRP20221118T1/hr unknown
- 2014-09-26 US US15/024,265 patent/US20160243234A1/en not_active Abandoned
- 2014-09-26 CN CN201480052814.8A patent/CN105658243B/zh active Active
- 2014-09-26 HU HUE14847119A patent/HUE060034T2/hu unknown
- 2014-09-26 DK DK14847119.6T patent/DK3049117T3/da active
- 2014-09-26 JP JP2016545714A patent/JP6876436B2/ja active Active
- 2014-09-26 PT PT148471196T patent/PT3049117T/pt unknown
- 2014-09-26 EP EP22151242.9A patent/EP4005604B8/en active Active
- 2014-09-26 ES ES22151242T patent/ES2951663T3/es active Active
-
2020
- 2020-03-25 JP JP2020054358A patent/JP7042862B2/ja active Active
-
2021
- 2021-05-14 US US17/302,917 patent/US20210299256A1/en active Pending
-
2023
- 2023-03-21 US US18/187,244 patent/US20230233681A1/en active Pending
- 2023-03-21 US US18/187,264 patent/US20230241216A1/en active Pending
- 2023-03-21 US US18/187,248 patent/US20230218759A1/en active Pending
- 2023-03-21 US US18/187,413 patent/US20230218760A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP4005604B1 (en) | 2023-06-07 |
EP4005604B8 (en) | 2023-07-19 |
EP3049117A1 (en) | 2016-08-03 |
WO2015047103A1 (en) | 2015-04-02 |
JP7042862B2 (ja) | 2022-03-28 |
PL3049117T3 (pl) | 2022-11-07 |
JP2016532718A (ja) | 2016-10-20 |
US20230218759A1 (en) | 2023-07-13 |
CN105658243A (zh) | 2016-06-08 |
HUE060034T2 (hu) | 2023-01-28 |
EP4005604C0 (en) | 2023-06-07 |
US20230233681A1 (en) | 2023-07-27 |
EP3049117A4 (en) | 2017-03-29 |
LT3049117T (lt) | 2022-10-10 |
ES2927884T3 (es) | 2022-11-11 |
JP2020114846A (ja) | 2020-07-30 |
EP4005604A1 (en) | 2022-06-01 |
HRP20221118T1 (hr) | 2022-12-23 |
US20160243234A1 (en) | 2016-08-25 |
CN105658243B (zh) | 2019-11-08 |
SI3049117T1 (sl) | 2022-11-30 |
US20230241216A1 (en) | 2023-08-03 |
US20230218760A1 (en) | 2023-07-13 |
ES2951663T3 (es) | 2023-10-24 |
JP6876436B2 (ja) | 2021-05-26 |
EP3049117B1 (en) | 2022-07-27 |
DK3049117T3 (da) | 2022-10-31 |
US20210299256A1 (en) | 2021-09-30 |
PT3049117T (pt) | 2022-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL3049117T3 (pl) | Dostarczanie leków za pomocą ultradźwięków | |
IL244259B (en) | Insertion of medical devices | |
HK1211517A1 (en) | Drug delivery device | |
HK1211520A1 (en) | Drug delivery device | |
EP3019081A4 (en) | Acoustic based drug delivery monitor | |
SG11201508647UA (en) | Drug delivery device | |
EP2961469A4 (en) | DEVICE FOR DELIVERY OF MEDICAMENT | |
HK1211519A1 (en) | Drug delivery device | |
GB201313782D0 (en) | Drug delivery device | |
SG11201600371XA (en) | Drug delivery device | |
HK1219451A1 (zh) | 藥物輸送裝置 | |
ZA201507576B (en) | Pharmaceutical combination drug | |
HK1219682A1 (zh) | 藥物輸送裝置 | |
HK1219450A1 (zh) | 藥物輸送裝置 | |
HK1219685A1 (zh) | 藥物輸送裝置 | |
HK1219681A1 (zh) | 藥物輸送裝置 | |
GB201419540D0 (en) | Delivery of drugs | |
HK1219680A1 (zh) | 藥物輸送裝置 | |
IL245618A0 (en) | Inhalation medicine | |
HK1221921A1 (zh) | 藥物輸送裝置 | |
IL245760A0 (en) | Inhalation medicine | |
HK1204916A1 (en) | Pharmaceutical application of anhydroicaritin | |
HK1223052A1 (zh) | 藥物輸送裝置 | |
IL245007A0 (en) | Drug release device | |
GB201319437D0 (en) | Delivery of drugs |